The following IPOs are expected to price this week:

Bright Horizons Family Solutions (BFAM), which is leading provider of work site child care and early education centers, plans to raise $202 million by offering 10.1 million shares at a price range of $19.00 to $21.00. At the midpoint of the proposed range, Bright Horizons Family Solutions would command a market value of $1.3 billion. Bright Horizons Family Solutions, which was founded in 1986, booked $1.0 billion in sales over the last 12 months. The Watertown, MA-based company plans to list on the NYSE under the symbol BFAM. Goldman Sachs, J.P. Morgan, Barclays and BofA Merrill Lynch are the joint bookrunners on the deal.

LipoScience (LPDX), which provides an LDL diagnostic test to assess cardiovascular disease risk, plans to raise $70 million by offering 5.0 million shares at a price range of $13.00 to $15.00. At the midpoint of the proposed range, LipoScience would command a market value of $212 million. LipoScience, which was founded in 1997, booked $54 million in sales over the last 12 months. The Raleigh, NC-based company plans to list on the NASDAQ under the symbol LPDX. Barclays, UBS Investment Bank and Piper Jaffray are the joint bookrunners on the deal.

Renaissance Capital will have Pre-IPO Research available on each of these upcoming IPOs prior to its pricing.

Last week, there were 5 IPO pricings. Norwegian Cruise Line (NCLH), a third largest cruise line operator in North America with 11% share, was the week's winner, ending up 30% from its IPO price.